维普期刊资源整合服务平台（V6.5）

191篇 您的检索式：作者名="LISSONI P"

选中清除导出查看参考文献查看引证文献引用追踪共10页首页上一页第1页下一页末页 /10 跳转

	题名	作者	年代	出处	被引量
1	Tumor necrosis factor in solid tumors: increased blood levels in the metastatic disease显示文摘	Ardizzoia A Lissoni P Brivio F	1992	J Biol Regul Homeost Agents1992，6，3：	1
2	Circulating immature and mature dendritic cells in relation to lymphocyte subsets in patients with gastrointestinal tract cancer显示文摘	Lissoni P Brivio E Ferrante R	2000	Int J Bio Markers2000，15，：	1
3	The biological significance of soluble interleukin-2 receptors in solid tumors显示文摘	Lissoni P Barni S Rovelli F	1990	Eur J Cancer1990，26，1：	1
4	Pre-operative IL-2 immunoprophylaxis of cancer recurrence:long-term clinical results of a phase Ⅱ study in radically operable colorectal cancer显示文摘	Brivio F Lissoni P Fumagalli L	1999	Oncol Rep1999，6，6：	1
5	Enhancement of the efficacy of chemotherpy with oxaliplatin plus 5-fluorouracil by pre-treatment with IL-2 subcutaneous immunotherapy in metastatic colorectal cancer patients with lymphocytopenia prior to therapy显示文摘	Lissoni P Brivio F Fumagalli L	2005	In Vivo2005，19，6：	1
6	Neuroimmunotherapy with low-dose subcutaneous interleukin-2 plus melatonin in AIDS patients with CD4 cell number below 200/mm3: a biological phase-II study显示文摘	Lissoni P Vigore L Rescaldani R	1995	J Biol Regul Homeost Agents1995，9，4：	1
7	Efficacy of cancer chemotherapy in relation to synchronization of cortisol rhythm, immune status and psychospiritual profile in metastatic non-small cell lung cancer显示文摘	Lissoni P Messina G Balestra A	2008	In Vivo2008，22，：	1
8	Which immunological parameters are clinically essential to monitor IL-2cancer immunotherapy显示文摘	Lissoni P Brivio F Viviani S	1999	J Biol Regul Homeost Agents1999，13，2：	1
9	A review on cancer psychospirtual status interactions显示文摘	Lissoni P Cangemi P Pirato D	2001	Neuroendocrinol Lett2001，22，3：	1
10	Biochemotherapy with standard chemotherapies plus the pineal hormone melatonin in the treatment of advanced solid neoplasms 显示文摘	Lissoni P	2007	Pathol Biol2007，55，34：	1
11	Circulating immature and mature dendritic cells in relation to lymphocyte subsets in patients with gastrointestinal tract cancer 显示文摘	Lissoni P Brivio F Ferrante R	2000	Int J Biol Markers2000，15，1：	1
12	A phase Ⅱ study of tamoxifen in hormone-resistant metastatic prostate cancer: possible relation with prolaetinseeretion显示文摘	Lissoni P Vigano P Vaghi M	2005	Anticancer Res2005，25，5：	1
13	Biochemotherapy with standard chemotherapies plus the pineal hormone melatonin in the treatment of advanced solid neoplasms显示文摘	Lissoni P	2007	Pathol Biol(Paris)2007，55，34：	1
14	Preoperative interleukin-2 subcutaneous immunotherapy may prolong the survival time in advanced colorectal cancer patients显示文摘	Brivio F Lissoni P Alderi G	1996	Oncology1996，53，4：	1
15	Low-dose interleukin-2 subcutaneous immunotherapy in association with the pineal hormone melatonin as a first-line therapy in locally advanced or metastatic hepatocellular carcinoma显示文摘	Lissoni P Barni S	1994	Eur J Cancer1994，30，2：	1
16	Circulating immature and maturc dendritic cells in relation to lymphocyte subsets in patients with gastrointestinal tract cancer 显示文摘	Lissoni P Brivio F Ferrante R	2000	Int J Biol Markets2000，12，1：	1
17	Modulation of cancer endocrine therapy by melatonin:a phase II study of tamoxifen plus melatonin in metastatic breast cancer patients progressing under ramoxifen alone显示文摘	Barin S Meregalli S	1995	Br J Cancer1995，71，4：	1
18	Biochemotherapy with standard chemotherapies plus the pineal hormone melatonin in the treatment of advanced solid neoplasms显示文摘	Lissoni P	2007	Pathologie Biologie2007，55，34：	1
19	Is there a role for melatonin in supportive care显示文摘	Lissoni P	2002	Support Care Cancer2002，10，2：	1
20	The biological significance of soluble interleukin-2 receptor in solid tumor 显示文摘	Lissoni P Barni S Rovelli F	1990	Eur J Cancer1990，26，1：	1

返回顶部每页显示：

共10页首页上一页第1页下一页末页 /10 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示